tiprankstipranks
pc:disco

DISCO Pharmaceuticals

Therapeutics
DISCO Pharmaceuticals is advancing a differentiated pipeline of highly selective, surfaceome-targeted therapies for hard-to-treat tumors. By uncovering novel cell surface target pairs through its disruptive platform, the company designs bispecific ADCs and T-cell engagers with the potential for unprecedented specificity and a broad therapeutic window to drive potent anti-tumor activity.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$36M
Total Amount Raised$36M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$36M
Latest Funding Amount$36M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 11, 2025
Seed Round
$36.00M
―

Investors

Investor Name
Funding Round
M Ventures
Seed Round
Sofinnova Partners
Seed Round
Ackermans & van Haaren (AvH)
Seed Round
AbbVie Ventures
Seed Round
NRW.Bank
Seed Round
Panakès Partners
Seed Round

Related News and Analysis

Ro Adds Lilly’s Oral GLP-1 Foundayo to Expand Obesity Treatment Platform

Ro Adds Lilly’s Oral GLP-1 Foundayo to Expand Obesity Treatment Platform

New updates have been reported about Ro. Ro has added Eli Lilly’s new oral GLP-1 drug Foundayo (orforglipron)...
21h ago
ROHLC
AllRock Bio Begins Phase 2a ROCSTAR Trial of Lead Pan-ROCK Inhibitor in Pulmonary Hypertension

AllRock Bio Begins Phase 2a ROCSTAR Trial of Lead Pan-ROCK Inhibitor in Pulmonary Hypertension

New updates have been reported about AllRock Bio. AllRock Bio, Inc. has initiated patient dosing in its Phase...
21h ago
ALLRO
Trogenix Preclinical Breakthrough in Glioblastoma Paves Way to First-in-Human Trial

Trogenix Preclinical Breakthrough in Glioblastoma Paves Way to First-in-Human Trial

New updates have been reported about Trogenix. Trogenix has published preclinical data in Nature showing complete tumor clearance...
22h ago
TROGE
Bedrock Data Recognized Among Fast-Growing Midsize Cybersecurity Firms

Bedrock Data Recognized Among Fast-Growing Midsize Cybersecurity Firms

According to a recent LinkedIn post from Bedrock Data, the company has been included in IT-Harvest’s 2026 Cyber...
1d ago
BED6Z
Cornerstone Robotics Showcases Sentire Surgical System at CMEF Shanghai

Cornerstone Robotics Showcases Sentire Surgical System at CMEF Shanghai

A LinkedIn post from Cornerstone Robotics highlights the company’s participation in the 93rd China International Medical Equipment Fair...
1d ago
CORNE
ClickHouse Targets Real-Time AI Data Workloads With Expanded Conference Presence

ClickHouse Targets Real-Time AI Data Workloads With Expanded Conference Presence

According to a recent LinkedIn post from ClickHouse, the company is planning a broad presence at the AI...
1d ago
CLHSE
Cohesity Highlights Cyber Resilience Focus, Nutanix Partnership and Customer Recognition

Cohesity Highlights Cyber Resilience Focus, Nutanix Partnership and Customer Recognition

According to a recent LinkedIn post from Cohesity, the company is emphasizing the limitations of largely manual and...
1d ago
COHSY
Cohesity Positions Data Recovery as Key Risk Mitigation for AI-Driven Security

Cohesity Positions Data Recovery as Key Risk Mitigation for AI-Driven Security

A LinkedIn post from Cohesity highlights the growing security risks tied to agentic artificial intelligence in enterprise environments....
1d ago
COHSY
AdvantageClubai Highlights Filipino Day of Valor and Workplace Culture Focus

AdvantageClubai Highlights Filipino Day of Valor and Workplace Culture Focus

According to a recent LinkedIn post from AdvantageClubai, the company is marking the Philippines’ Araw ng Kagitingan (Day...
1d ago
ADVAN
Flexport Capital Spotlighted as Growth Financing Partner for Portland Leather Goods

Flexport Capital Spotlighted as Growth Financing Partner for Portland Leather Goods

According to a recent LinkedIn post from Flexport, Portland Leather Goods reportedly shifted away from an institutional investor...
1d ago
FLEXP